Angiotensinogen M235T polymorphism and left ventricular indices in treated hypertensive patients with normal coronary arteries

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue 3, 2007, Pages 257-261

  Olkay, Ayhan ^a   Nişansi, Yilmaz ^a   Ekmekçi, C Gökhan ^a   Özbek, Uǧur ^a   Sezer, Murat ^a   Umman, Berrin ^a   Buǧra, Zehra ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Angiotensinogen; Coronary arteries; Genotypes; Hypertension; Left ventricular hypertrophy

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DRUG RESPONSE; ECHOCARDIOGRAPHY; FEMALE; GENOTYPE; HEART DILATATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OUTPATIENT CARE; PREDICTION; PROTEIN POLYMORPHISM; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

ANGIOTENSINOGEN; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; TURKEY;

EID: 34648843547     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. MacMahon S, Peto R, Cutler J, Collins R, Sodie P, Neaton J, et al. Blood pressure, stroke and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
2. Ward R. Familial Aggregation and genetic epidemiology of blood pressure. New York: Raven Pres; 1995.
3. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, et al. A chimeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355: 262-5.
4. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Shambelan M, et al. Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel, Cell 1994; 79: 407-14.
5. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nat Genet 1995; 10: 394-9.
6. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
7. Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA 1994; 272: 33-6.
8. Schillaci G, Verdecchia P, Reboldi G, Pede S, Porcellati C. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-6.
9. Adams TD, Yanowitz FG, Fisher AG, Ridges JD, Nelson AG, Hagan AD, et al. Heritability of cardiac size: echocardiographic and electrocardiographic study of monozygotic and dizygotic twins. Circulation 1985; 71: 39-44.
10. Allemann Y, Aeschbacher B, Zwyssig P, Ferrari P, Hopf M, Shaw S, et al. Left ventricular structure and determinants in normotensive offsprings of essential hypertensive patients. J Hypertens 1992; 10. 1257-64.
11. Scbunkert H, Brockel U, Hengstenberg C, Luchner A, Muscholl MW, Kurzidim K, et al. Familial predisposition to left ventricular hypertrophy. J Am Coll Cardiol 1999; 33: 1685-91.
12. Post WS., Larson MG., Myers RH. Heritability of left ventricular mass: The Framingham Heart Study. Hypertension 1997; 30: 1025-8.
13. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90: 1786-93.
14. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97: 48-54.
15. Malmqvist K, Kahan T, Ender M, Held C, Hagg A, Lind L, et al. Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens 2001; 19: 1167-76.
16. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Öhman P, et al. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type I antagonist treatment in hypertensive patients. J Hypertens 2001; 19: 1783-7.
17. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Öhman P, et al. Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA) trial. J Hypertens 2002; 20: 657-63.
18. Jeunemaitre X, Soubder F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-80.
19. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, et al, Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93: 1285-7.
20. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, et al. M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993; 11 (5 Suppl): S80-1.
21. Bloem LJ, Manatunga AK, Tewksbun DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995; 95: 948-53.
22. Schunkert H, Hense HW, Muscholl M, Luchner A, Kurzinger S, Danser AH, et al. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart 1997; 77: 24-31.
23. Winkelmann BR, Russ AP, Nauck M, Klein B, Bohm BO, Maier V, et al. Angiotensinogen M235 polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J 1999; 137: 698-705.
24. Ishanov A, Okamoto H, Yoneya K, Watanabe M, Nakagawa I, Machida M, et al. Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J 1997; 133: 184-9.
25. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensin gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease. A meta-analysis. Arterioscler Thromb Vasc Biol 2003; 23: 1269-75.
26. Gardemann A, Stricker J, Humme J, Nguyen OD, Katz N, Philipp M, et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis 1999; 145: 309-14.
27. Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E, Ruiz-Galdon M, Espinosa-Caliani S, Aranda-Lara P, et al. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. Clin Genet 2001; 60: 52-7.
28. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786-97.
29. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60: 1448-60.
30. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55:613-8
31. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for the quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-67.
32. Agachan B, Isbir T, Yilmaz H, Akoglu E. Angiotensin converting enzyme I/ D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp Mol Med 2003; 35: 545-9.
33. Rodriguez-Perez JC, Rodriguez-Esparragon F, Hernandez-Perera O, Anabitarte A, Losada A, Medina A, et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: The Procagene study. J Am Coll Cardiol 2001; 37: 1536-42.
34. Olivieri O, Stranieri C, Girelli D, Pizzolo F, Grazioli S, Russo C, et al. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease. J Hypertens 2001; 19: 879-84.